Skip Navigation
SummeRun
Get the latest news

Rivkin Center and Women’s Cancer Advocacy Group CanCan Join Forces

  • Press Release

The Rivkin Center for Ovarian Cancer has merged with CanCan to add ovarian and breast cancer education and awareness as the third component of its programming, which to date has focused exclusively on ovarian cancer research and early detection screening.

Read More

BRCA Testing Increasing Among Young Breast Cancer Patients

  • Cancer Network

Young women with breast cancer increasingly undergo genetic testing for BRCA1 and BRCA2 mutations, according to a new study.

Read More

The Lester and Bernice Smith Foundation Gift Helps The Rivkin Center for Ovarian Cancer Launch New Challenge Grant

  • Press Release

The Rivkin Center for Ovarian Cancer announced today that it will award a new $150,000 Challenge Grant in 2016. This two-year grant is focused on producing a new finding that could significantly improve our understanding of ovarian cancer. This will be the largest award currently offered by the Rivkin Center. …

Read More

Rivkin Center Celebrating 20th Anniversary

  • Press Release

The Marsha Rivkin Center for Ovarian Cancer Research is celebrating its 20th Anniversary in 2016. To celebrate this milestone, the organization is changing its name to the Rivkin Center for Ovarian Cancer. …

Read More

UK Collaborative Trial of Ovarian Cancer Screening Study Results Published

  • Press Release

Today the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) reported results of its 14 year-long study, which showed that ovarian cancer screening may reduce ovarian cancer mortality by up to 20% …

Read More

Older Women Received Less Treatment for Ovarian Cancer

  • Cancer Network

A French study showed women over 70 received less treatment for ovarian cancer than their younger counterparts, regardless of stage or grade of their disease. …

Read More

Nintedanib Delays Progression of Advanced Ovarian Cancer

  • Cancer Network

Women with chemotherapy-naïve advanced ovarian cancer gained significant delays in the progression of their disease when they were treated with nintedanib plus carboplatin/paclitaxel. …

Read More

Why Groundbreaking New Cancer Drugs Still Don’t Work for Most Patients

  • The Washington Post

Tumors with a high concentration of “T cells,” a type of white blood cell, were more responsive to treatment, whereas tumors with a low number of T cells were far less responsive. The Rivkin Center funded scientist Ilona Kryczek, PhD to work on the mouse models of ovarian cancer cells used in this study. …

Read More

Research Explains Limits of Cancer Immunotherapy Drugs

  • University of Michigan Health System

Research from Rivkin Center Scientific Advisory Board member Dr. Weiping Zou MD, PhD published in the journal Nature reveals molecular changes within the tumor that are preventing immunotherapy drugs from killing off cancer. …

Read More

Hormone Therapy May Improve Ovarian Cancer Survival

  • Cancer Network

According to results of a study published in the Journal of Clinical Oncology, hormone therapy was safely administered in women with severe menopausal symptoms and may have a beneficial effect on survival. …

Read More

Challenge Grant Award

Scientist in lab

Challenge Grant Deadline Submission

This grant competition is open February 1 – March 25, 2016. To be eligible, initial applications must be received by March 25, 2016 (5pm PT).

Apply Now

Grant award recipient authored publications published by top scientific journals: 55%